Sarepta Therapeutics Names Basi Chief Scientific Officer

Xconomy Boston — 

Sarepta Therapeutics (NASDAQ: SRPT) has a new chief scientific officer. Guriqbal Basi has been appointed to the post, where he will oversee the Cambridge, MA, company’s rare disease drug pipeline. Basi’s 30 years of pharmaceutical industry experience includes several leadership roles at the former Ireland-based drug company Elan, now part of Perrigo (NYSE: PRGO).